Dabigatran Etexilate 75 mg/1 (Dabigatran Etexilate CAPSULE, COATED PELLETS) 75 mg/1

Dabigatran Etexilate 75 mg capsules are an oral medication used to prevent blood clots. This anticoagulant is commonly prescribed for conditions requiring blood thinning, such as atrial fibrillation.

Strength

75 mg/1

Pack Size

6 BLISTER PACK in 1 CARTON (0904-7253-68) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7253

Manufacturer / TM Owner

Major Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dabigatran Etexilate is primarily used to reduce the risk of blood clots and stroke in patients with atrial fibrillation. It is also used to treat deep vein thrombosis and pulmonary embolism. This medication works by inhibiting thrombin, a key enzyme in blood clotting. Patients often ask, 'What is Dabigatran Etexilate used for?' It is typically prescribed for long-term management of conditions that require anticoagulation.

Side Effects

Common effects of Dabigatran Etexilate may include bleeding, bruising, and gastrointestinal discomfort. Some users report dizziness or nausea. It is important to monitor for signs of unusual bleeding, as this medication affects blood clotting.

Precautions & Warnings

Dabigatran Etexilate should be handled with care, especially in patients with a history of bleeding disorders or kidney problems. It is crucial to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Store in a cool, dry place away from direct sunlight.

Avoid Interactions

Dabigatran Etexilate may interact with other blood thinners, NSAIDs, and certain antibiotics. Alcohol consumption should be limited, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Dabigatran Etexilate is used to prevent blood clots and reduce the risk of stroke in patients with atrial fibrillation. It is also used to treat deep vein thrombosis and pulmonary embolism.

Dabigatran Etexilate is taken orally, typically once or twice daily, depending on the prescription. It should be taken with water and can be taken with or without food.

Common side effects include bleeding, bruising, and gastrointestinal discomfort. Some users may experience dizziness or nausea.

Dabigatran Etexilate may interact with other blood thinners, NSAIDs, and certain antibiotics. Always consult a healthcare provider before combining medications.

Dabigatran Etexilate should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.